C-reactive Protein Testing Market Size, Share, Growth Analysis, By Assay Type(Immunoturbidimetric Assay, Chemiluminescence Immunoassay, ELISA, others), By Disease Area(Cardiovascular Diseases, Cancer, Lupus, Endometriosis), By End-Use(Clinics, Hospitals, Laboratories, others), By Region - Industry Forecast 2024-2031

C-reactive Protein Testing Market size was valued at USD 3066.45 million in 2019 and is poised to grow from USD 3118.68 million in 2023 to USD 3568.69 million by 2031, growing at a CAGR of 2.4% in the forecast period (2024-2031).

Rising advancements in nanotechnological tools coupled with the high specificity, sensitivity, and a faster response time for on-site diagnosis and monitoring of diseases are the key factors expected to drive the growth of the global market during the forecast period. In addition, the rising study demonstrated the use of newly developed and designed point-of-care assays for rapid testing of CRP. This is anticipated to fuel the demand for the global market over the coming years. For instance, according to NCBI, the researchers of Mohammed VI University of Health Sciences, Morocco, successfully studies the use of C-reactive protein as a type of early detector of SARS-CoV-2 infection severity.

Furthermore, rising prevalence of inflammatory disorders, diabetes, and cancers are the major factors propelling the growth of the global C-reactive protein testing market during the forecast period. Increasing incidence of endometriosis in women globally coupled with the rise in funding in diagnostics sector and adoption of point-of-care devices are further projected to paved the way for market growth at a significant pace. For instance, according to Center for Disease Control and Prevention, in July 2022, there were around 20.1 million adults aged over 20 years suffering from coronary artery disease in the United States, and is estimated to grow more in the near future.

US C-reactive Protein Testing Market is poised to grow at a sustainable CAGR for the next forecast year.